Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbazole scaffolds in cancer therapy: a review from 2012 to 2018.
Issa S, Prandina A, Bedel N, Rongved P, Yous S, Le Borgne M, Bouaziz Z. Issa S, et al. Among authors: le borgne m. J Enzyme Inhib Med Chem. 2019 Dec;34(1):1321-1346. doi: 10.1080/14756366.2019.1640692. J Enzyme Inhib Med Chem. 2019. PMID: 31328585 Free PMC article. Review.
Synthesis and antileishmanial activity of 3-(alpha-azolylbenzyl)indoles.
Marchand P, Le Borgne M, Na YM, Pagniez F, Abdala H, Le Baut G, Le Pape P. Marchand P, et al. Among authors: le baut g, le pape p, le borgne m. J Enzyme Inhib Med Chem. 2002 Dec;17(6):353-8. doi: 10.1080/1475636021000005613. J Enzyme Inhib Med Chem. 2002. PMID: 12683669
Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds.
Bouaziz Z, Issa S, Gentili J, Gratz A, Bollacke A, Kassack M, Jose J, Herfindal L, Gausdal G, Døskeland SO, Mullié C, Sonnet P, Desgrouas C, Taudon N, Valdameri G, Di Pietro A, Baitiche M, Le Borgne M. Bouaziz Z, et al. Among authors: le borgne m. J Enzyme Inhib Med Chem. 2015 Apr;30(2):180-8. doi: 10.3109/14756366.2014.899594. Epub 2014 Apr 3. J Enzyme Inhib Med Chem. 2015. PMID: 24697298
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
Jabor Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Aichele D, Nacereddine A, Marminon C, Valdameri G, Zeinyeh W, Bollacke A, Guillon J, Lacoudre A, Pinaud N, Cadena SM, Jose J, Le Borgne M, Di Pietro A. Jabor Gozzi G, et al. Among authors: le borgne m. J Med Chem. 2015 Jan 8;58(1):265-77. doi: 10.1021/jm500943z. Epub 2014 Oct 16. J Med Chem. 2015. PMID: 25272055
Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells.
de Ravel MR, Alameh G, Melikian M, Mahiout Z, Emptoz-Bonneton A, Matera EL, Lomberget T, Barret R, Rocheblave L, Walchshofer N, Beltran S, El Jawad L, Mappus E, Grenot C, Pugeat M, Dumontet C, Le Borgne M, Cuilleron CY. de Ravel MR, et al. Among authors: le borgne m. J Med Chem. 2015 Feb 26;58(4):1832-45. doi: 10.1021/jm501676v. Epub 2015 Feb 11. J Med Chem. 2015. PMID: 25634041
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.
Gozzi GJ, Bouaziz Z, Winter E, Daflon-Yunes N, Honorat M, Guragossian N, Marminon C, Valdameri G, Bollacke A, Guillon J, Pinaud N, Marchivie M, Cadena SM, Jose J, Le Borgne M, Di Pietro A. Gozzi GJ, et al. Among authors: le borgne m. Drug Des Devel Ther. 2015 Jul 3;9:3481-95. doi: 10.2147/DDDT.S84982. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26170632 Free PMC article.
128 results